These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 915577)

  • 1. A rapid, efficient synthesis of oxytocin and 8-arginine-vasopressin. Comparison of benzyl, p-methoxybenzyl, and p-methylbenzyl as protecting groups for cysteine.
    Live DH; Agosta WC; Cowburn D
    J Org Chem; 1977 Oct; 42(22):3556-61. PubMed ID: 915577
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of peptides by fragment condensation on a solid support. II. A scheme for preparation of 4,8-disubstituted vasopressins evaluated on 8-arginine-vasopressin.
    Larsson LE; Melin P; Ragnarsson U
    Int J Pept Protein Res; 1976; 8(1):39-44. PubMed ID: 1248925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of specific deuterium labeled tyrosine and phenylalanine derivatives and their use in the total synthesis of [8-arginine]vasopressin derivatives: The separation of diastereomeric [8-arginine]vasopressin derivatives by partition chromatography1,2.
    Yamamoto DM; Upson DA; Linn DK; Hruby VJ
    J Am Chem Soc; 1977 Mar; 99(5):1564-70. PubMed ID: 839004
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical syntheses and biological studies on dimeric chimeras of oxytocin and the V(2)-antagonist, d(CH(2))(5)[D-Ile(2), Ile(4)]arginine vasopressin.
    Chen L; Golser R; Machová A; Slaninová J; Barany G
    J Med Chem; 1999 Dec; 42(24):5002-9. PubMed ID: 10585209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
    Nestor JJ; Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1-(L-2-hydroxy-3-mercaptopropanoic acid)] analogues of arginine-vasopressin, [8-D-arginine]vasopressin, and [4-valine,8-D-arginine]vasopressin.
    Lowbridge J; Manning M; Haldar J; Sawyer W
    J Med Chem; 1977 Sep; 20(9):1173-6. PubMed ID: 926117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13C nuclear magnetic resonance studies of the interactions of bovine neurophysins with (1-hemi-(1-13C)cystine)oxytocin and (1-hemi-(1-13C)cystine,8-arginine)vasopressin.
    Blumenstein M; Hruby VJ; Yamamoto D; Yang Y
    FEBS Lett; 1977 Sep; 81(2):347-50. PubMed ID: 923806
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Physiological studies of arginine-vasopressin by radioimmunoassay with two immunologically distinct antisera.
    Thomas TH; Lee MR
    J Endocrinol; 1976 Jun; 69(3):5P. PubMed ID: 950544
    [No Abstract]   [Full Text] [Related]  

  • 10. Levels of arginine-vasopressin and oxytocin in the pituitary gland and individual hypothalamic nuclei of the genetically obese Zucker rat.
    Crowley WR; George JM; Jacobowitz DM
    J Endocrinol; 1978 Jun; 77(3):417-8. PubMed ID: 660081
    [No Abstract]   [Full Text] [Related]  

  • 11. Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule.
    Kowalczyk W; Prahl A; Derdowska I; Sobolewski D; Olejnik J; Zabrocki J; Borovicková L; Slaninová J; Lammek B
    J Med Chem; 2006 Mar; 49(6):2016-21. PubMed ID: 16539389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly specific antiserum for arginine vasopressin.
    Moore G; Lutterodt A; Burford G; Lederis K
    Endocrinology; 1977 Nov; 101(5):1421-35. PubMed ID: 913320
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbon-13 nuclear magnetic resonance studies of the interaction of specifically labeled (90%-13C) oxytocin and arginine vasopressin with neurophysins.
    Blumenstein M; Hruby VJ
    Biochem Biophys Res Commun; 1976 Feb; 68(4):1052-8. PubMed ID: 1267763
    [No Abstract]   [Full Text] [Related]  

  • 14. Partial purification and characterization of post-proline cleaving enzyme: enzymatic inactivation of neurohypophyseal hormones by kidney preparations of various species.
    Walter R
    Biochim Biophys Acta; 1976 Jan; 422(1):138-58. PubMed ID: 2300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular considerations in the interaction of arginine vasopressin with a specific antiserum.
    Burford G; Lutterodt A; Moore G; Lederis K
    Proc West Pharmacol Soc; 1977; 20():521-5. PubMed ID: 896861
    [No Abstract]   [Full Text] [Related]  

  • 17. CYSTEINE EFFECT ON TOAD BLADDER RESPONSE TO VASOPRESSIN, CYCLIC AMP, AND THEOPHYLLINE.
    HANDLER JS; ORLOFF J
    Am J Physiol; 1964 Mar; 206():505-9. PubMed ID: 14160974
    [No Abstract]   [Full Text] [Related]  

  • 18. Arginine-vasopressin, lysine-vasopressin, and oxytocin, C14-labeled in the glycine residue.
    Walter R; Havran RT
    Experientia; 1971 Jun; 27(6):645-6. PubMed ID: 5556440
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of some activities of arginine vasopressin and lysine vasopressin on kidney function in conscious dogs.
    ALI MN
    Br J Pharmacol Chemother; 1958 Jun; 13(2):131-7. PubMed ID: 13536276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),4-valine,-8-D-arginine]vasopressin, a potent and selective inhibitor of the vasopressor response to arginine-vasopressin.
    Lowbridge J; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1978 Mar; 21(3):313-5. PubMed ID: 628009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.